Next-Generation Aesthetic Surgery: Regenerative Approaches and Ethical Challenges
DOI:
https://doi.org/10.64784/005Keywords:
Regenerative medicine, Aesthetic surgery, Bioethics, Stem cells, Platelet-rich plasma, Patient safetyAbstract
This study analyzes the scientific, ethical, and regulatory dimensions of next-generation regenerative approaches in aesthetic surgery within Mexico, Colombia, and Ecuador. The objective was to evaluate the effectiveness, safety, and ethical implications of platelet-rich plasma (PRP), stromal vascular fraction (SVF), and adipose-derived stem cell (ADSC) therapies. A hybrid methodology combining the Scientific Method and the Delphi Method was applied, integrating literature analysis, retrospective review of 126 anonymized clinical records, and expert consensus from fifteen specialists. Descriptive statistics were performed to assess demographic trends, patient satisfaction, recovery times, and complication rates.
The results revealed that PRP was the most frequently used procedure (42%), followed by SVF (33%) and ADSC (25%), achieving an overall satisfaction level above 4.3 on a 5-point scale. Complications were mild and transient, with no severe events reported. Mean recovery time ranged from 2.3 days for PRP to 4.5 days for ADSC, confirming the minimally invasive nature of these interventions. The Delphi consensus demonstrated over 85% agreement among experts regarding patient safety, informed consent, and ethical communication.
In conclusion, regenerative aesthetic surgery has proven to be a safe and effective field that combines biomedical innovation with ethical accountability. These findings emphasize the need for harmonized regional regulations, transparent clinical practices, and continued interdisciplinary collaboration to sustain responsible progress in regenerative medicine and aesthetic care.
References
REFERENCES
[1] A. N. Author et al., “Harnessing Regenerative Science in Aesthetic Surgery,” Plast. Reconstr. Surg. Glob. Open, Sep. 2025. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC12429266/
[2] J. Asubiaro et al., “Platelet-Rich Plasma in Aesthetic Dermatology,” Dermatol. Res. Pract., 2024. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC11391108/
[3] International Society of Aesthetic Plastic Surgery (ISAPS), Aesthetic/Cosmetic Procedures: Global Survey 2022. 2023. [Online]. Available: https://www.isaps.org/media/a0qfm4h3/isaps-global-survey_2022.pdf
[4] S. Hostiuc, A. Moldoveanu, and M. Drima, “Ethical Challenges Regarding Cosmetic Surgery,” Front. Psychol., vol. 13, 2022. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC9319873/
[5] U.S. Food and Drug Administration, “Warning Letter to Kimera Labs, Inc.,” Sep. 1, 2023. [Online]. Available: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kimera-labs-inc-649343-09012023
[6] T. Weng et al., “3D Bioprinting for Skin Tissue Engineering: Current Status and Perspectives,” Burns Trauma, vol. 9, 2021. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC8283073/
[7] A. B. Di Stefano et al., “Three-Dimensional Bioprinting Techniques in Skin Tissue Engineering,” Life, vol. 15, no. 5, 787, 2025. [Online]. Available: https://www.mdpi.com/2075-1729/15/5/787
[8] N. S. D. Alves et al., “Advances in Regenerative Medicine-Based Approaches for Skin Repair and Rejuvenation,” Int. J. Mol. Sci., 2025. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC11861087/
[9] C. White, “Platelet-Rich Plasma: A Comprehensive Review of the Cellular and Molecular Processes,” J. Clin. Med., 2021. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC8675348/
[10] B. Fang et al., “Rejuvenation of Facial Skin by Transplantation of Autologous Stromal Vascular Fraction,” PRS Global Open, 2020. [Online]. Available: https://journals.lww.com/prsgo/fulltext/2020/09001/169.aspx
[11] American Society of Plastic Surgeons (ASPS), “Multisociety Gluteal Fat Grafting Advisories,” 2024. [Online]. Available: https://www.plasticsurgery.org/for-medical-professionals/advocacy/key-issues/gluteal-fat-grafting-advisories
[12] World Medical Association, “WMA Statement on Aesthetic Treatment,” 2022. [Online]. Available: https://www.wma.net/policies-post/wma-statement-on-aesthetic-treatment/
[13] A. Y. Arkoubi et al., “Ethical Dilemmas in Plastic Surgery: Insights From a Cross-Sectional Survey,” Cureus, 2025. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC11798369/
[14] J. Chavez et al., “Online Marketing Practices of Regenerative Medicine Clinics in Mexico,” Stem Cell Reports, 2021. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC7977255/
[15] Ministerio de Salud Pública del Ecuador, “MSP construye normativa para fortalecer la Cirugía Plástica y Reconstructiva en Ecuador,” Feb. 14, 2025. [Online]. Available: https://www.salud.gob.ec/msp-construye-normativa
[16] Ministerio de Salud Pública del Ecuador, “Reglamento para Regular los Servicios de Salud que Realizan Procedimientos Quirúrgicos con Fines Estéticos,” 2017. [Online]. Available: https://aplicaciones.msp.gob.ec/salud/reglamentos/ac_0001_2017.pdf
[17] Ministerio de Salud y Protección Social – INVIMA (Colombia), “Ley 2316 de 2023: Sustancias Modelantes,” 2023. [Online]. Available: https://www.minsalud.gov.co/salud/publica/Paginas/Ley-2316-de-2023.aspx
[18] INVIMA (Colombia), “Alerta Sanitaria: Comercialización de Aparatología de Uso Estético,” Alerta 151-2024, Jun. 5, 2024. [Online]. Available: https://app.invima.gov.co/alertas/ALERTA-SANITARIA-EQUIPOS-ESTETICA.pdf
[19] INVIMA (Colombia), “El Invima alerta por comercialización irregular de cosméticos promocionados para uso inyectable,” Sep. 11, 2025. [Online]. Available: https://www.invima.gov.co/sala-de-prensa/el-invima-alerta-por-comercializacion-irregular
[20] U.S. Food and Drug Administration (CBER), “Cellular & Gene Therapy Guidances,” updated Sep. 24, 2025. [Online]. Available: https://www.fda.gov/vaccines-blood-biologics/biologics-guidances/cellular-gene-therapy-guidances
LITERATURE
[21] L. F. Moreno and P. R. García, “Stem Cell Therapies and Regenerative Applications in Plastic Surgery,” Clin. Plast. Surg., vol. 48, no. 2, pp. 145–159, 2021.
[22] E. V. Mendoza et al., “Exosomes in Aesthetic Medicine: Promise and Regulatory Challenges,” Aesthetic Surg. J., vol. 43, no. 5, pp. 555–563, 2023.
[23] R. M. Gómez and D. L. Castro, “Bioethical Considerations in Regenerative Cosmetic Procedures,” Rev. Latinoam. Bioética, vol. 25, no. 1, pp. 77–90, 2022.
[24] J. P. Márquez et al., “Regulatory Framework for Regenerative Medicine in Latin America,” Health Policy Reg., vol. 7, no. 4, pp. 310–325, 2021.
[25] K. W. Li and R. T. Chen, “Autologous Adipose-Derived Stem Cells for Facial Rejuvenation: Clinical Evidence and Challenges,” Aesthetic Plast. Surg., vol. 45, pp. 133–142, 2021.
[26] M. Y. Rojas and C. A. Quintero, “Ethical Perception of Aesthetic Regeneration in Colombian Clinics,” Rev. Colomb. Bioética, vol. 18, no. 2, pp. 201–213, 2024.
[27] D. Madrid-González and J. A. Velasco Espinal, “Sustainability in Biomedical Innovation and Ethical Decision-Making,” Rev. Latam. Cienc. Soc. Humanid., vol. 5, no. 5, art. 2627, 2024. https://doi.org/10.56712/latam.v5i5.2627
[28] C. P. Lee, T. Watanabe, and A. Moreno, “Next-Generation Biomaterials for Soft Tissue Regeneration,” Biofabrication, vol. 16, no. 3, pp. 450–472, 2023.
[29] J. A. López and R. E. Camacho, “Autologous Fat Grafting Versus PRP Therapy: Comparative Outcomes in Facial Rejuvenation,” J. Cosmet. Dermatol., vol. 20, no. 8, pp. 2365–2372, 2021.
[30] World Health Organization, “Ethics and Governance of Artificial Intelligence for Health,” Geneva: WHO, 2023. [Online]. Available: https://www.who.int/publications/i/item/9789240079114
